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Simple Summary: Due to social obligations (e.g., school, work), people shift their sleep and activity
time regardless of their sleep-wake preference. To compensate for the lack of sleep accumulated
over the workdays, people tend to oversleep on a work-free day. This difference in sleep timing
between workdays and free days resembles traveling across different time zones, which causes jetlag
(a mild form of circadian disruption). Thus, it is named social jetlag. Social jetlag has been linked
with obesity, metabolic disorders, and cardiovascular risk in previous research. This study assessed
social jetlag in 7455 cancer-free men in Alberta’s Tomorrow Project and followed them for on average
9.6 years, 250 men were diagnosed with prostate cancer. The study found that the more social jetlag
men experienced, the greater their prostate cancer risk was. This finding warrants future research to
better understand the complex behavioral and biological pathways between social jetlag and prostate
cancer risk.
Abstract: We investigated the association of social jetlag (misalignment between the internal clock
and socially required timing of activities) and prostate cancer incidence in a prospective cohort
in Alberta, Canada. Data were collected from 7455 cancer-free men aged 35–69 years enrolled in
Alberta’s Tomorrow Project (ATP) from 2001–2007. In the 2008 survey, participants reported usual
bed- and wake-times on weekdays and weekend days. Social jetlag was defined as the absolute
difference in waking time between weekday and weekend days, and was categorized into three
groups: 0–<1 h (from 0 to anything smaller than 1), 1–<2 h (from 1 to anything smaller than 2),
and 2+ h. ATP facilitated data linkage with the Alberta Cancer Registry in June 2018 to determine
incident prostate cancer cases (n = 250). Hazard ratios (HR) were estimated using Cox proportional
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hazards regressions, adjusting for a range of covariates. Median follow-up was 9.57 years, yielding
68,499 person-years. Baseline presence of social jetlag of 1–<2 h (HR = 1.52, 95% CI: 1.10 to 2.01),
and 2+ hours (HR = 1.69, 95% CI: 1.15 to 2.46) were associated with increased prostate cancer risk vs.
those reporting no social jetlag (p for trend = 0.004). These associations remained after adjusting for
sleep duration (p for trend = 0.006). With respect to chronotype, the association between social jetlag
and prostate cancer risk remained significant in men with early chronotypes (p for trend = 0.003) but
attenuated to null in men with intermediate (p for trend = 0.150) or late chronotype (p for trend = 0.381).
Our findings suggest that greater than one hour of habitual social jetlag is associated with an increased
risk of prostate cancer. Longitudinal studies with repeated measures of social jetlag and large samples
with sufficient advanced prostate cancer cases are needed to confirm these findings.
Keywords: social jetlag; circadian disruption; prostate cancer incidence
1. Introduction
Prostate cancer is the second most frequently diagnosed cancer, as well as the second-highest cause
of cancer death among men globally [1]. However, the etiology of prostate cancer is poorly understood
with very few risk factors identified thus far. Increasing age, African descent, and genetic predisposition
have been suggested to increase the risk of developing prostate cancer [2]. Modifiable risk factors
are not well known, but may include dietary components [2], selected occupational exposures [3],
physical activity, and body composition (particularly visceral fat and thigh subcutaneous fat) [4,5].
Another factor that has been consistently associated with prostate cancer risk is circadian disruption,
such as overly short or long sleep durations [6], late sleep timing [7], night shift work [7,8], and light
cycle alteration [9]. However, social jetlag, a highly prevalent form of chronic circadian disruption [10],
has been understudied in relation to prostate cancer risk.
Social jetlag refers to the misalignment between the internal clock and the socially required
timing of activities [11] and can be operationally defined as the phenomenon that many individuals
travel between socially imposed schedules on workdays and non-obligatory arrangements during free
days [12]. Social jetlag resembles a mild yet chronic form of night shift work [13] and has been associated
with obesity [10], depression [14], metabolic disorder [15,16], and adverse endocrine, behavioral,
and cardiovascular risk profiles [17]. Similar to other forms of circadian disruption, social jetlag can
misalign internal biological time organization with social timing constraints, resulting in unhealthy
lifestyle behaviors such as smoking and possible alternations of the metabolic pathways [11].
Previous research suggested that social jetlag interacts with individual chronotype,
the inter-individual differences in the phase of entrainment to the light-dark cycle [18], which may affect
cancer risk. Having a late chronotype is associated with a greater risk of developing cancer compared
to having an early chronotype, possibly due to more exposure to light at night and suppression of
melatonin secretion [7,19]. Given that chronotype and desynchronization in sleep rhythm interact,
previous studies included both circadian disruption and chronotype when assessing behavioral and
clinical outcomes [7]. Papantoniou et al. [7] also found that the elevated prostate cancer risk among
night shift workers was strongest for evening chronotypes, as well as morning chronotypes after
long-term night work, suggesting an effect modification of chronotype. However, it is not clear whether
this modification by chronotype exists for the association between social jetlag and prostate cancer risk.
To address these knowledge gaps, we prospectively investigated the association between social
jetlag and prostate cancer incidence, and the potential effect modification of chronotype on this
association in the Alberta’s Tomorrow Project (ATP) cohort [20].
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2. Materials and Methods
2.1. Study Design and Population
The design, recruitment, enrolment, and data collection of the ATP cohort have been detailed
elsewhere [21]. In brief, a total of 55,530 Albertans aged 35–69 with no personal history of cancer
(other than non-melanoma skin cancer) were enrolled in a prospective cohort study between 2001 and
2015. Participants enrolled between 2001 and 2007 completed a survey in 2008 and constituted as the
study baseline. Data were extracted on cancer-free men in the ATP cohort. All participants provided
informed consent that their survey data could be used for research purposes and ethical approval was
obtained from the Health Research Ethics Board of Alberta—Cancer Committee (HREBA.CC-19-0151
approved on 14 May 2019).
2.2. Ascertainment of Prostate Cancer
Participants were linked to the Alberta Cancer Registry with personal health numbers and
followed to establish new cancer diagnoses. The Alberta Cancer Registry is a population-based registry,
to which all physicians and laboratories in Alberta are mandated to report cancer diagnoses. The last
data linkage occurred in June 2018.
2.3. Social Jetlag and Chronotype
In the 2008 survey (baseline), participants were asked to report their usual bed- and wake-time
on weekday and weekend days in AM/PM, hour and minutes, respectively using the following
questions: “On average over the past 7 days, at what time did you normally go to sleep on a weekday?”;
“On average over the past 7 days, at what time did you normally wake up on a weekday?”; “On average
over the past 7 days, at what time did you normally go to sleep on a weekend day?’ and “On average
over the past 7 days, at what time did you normally wake up on a weekend day?”. In total, 7455 male
Albertans who were cancer-free at the time of survey completion provided responses on the bed-
and wake-times for the present study. Social jetlag was defined as the absolute difference in wake
times between weekend days and weekdays [22]. Social jetlag was categorized into three groups by a
one-hour increment in accordance with previous studies: 0–<1 h (45.6% of the sample population),
1–<2 h (29.6%), and 2+ hours (24.8%) [23,24]. Chronotype was defined by the tertiles of the sleep-time
midpoint on free days (wake-time −1/2 total sleep duration), and categorized as an intermediate, early,
or late sleep timing midpoint [6].
2.4. Covariates
A range of covariates were selected based on prior knowledge [25] including participant age at
baseline, total household income (CAD $0 to $49,999; $50,000 to $99,999; ≥ $100,000), employment
status (employed; unemployed), marital status (married, or living with a partner; divorced, separated,
or widowed; single, never married), family history of cancer (yes; no), body mass index (BMI, measured
in kg/m2) (normal/underweight: <25; overweight: 25 to <30; obese: 30+), smoking behavior (never
smoker; former smoker; current smoker), drinking behavior (never drinker; rarely drinker; occasional
drinker; regular drinker), the highest level of attained education (at least some post-secondary;
the secondary school or less), history of any medical condition (yes; no), recreational physical activity
(zero; non-zeroes grouped into quartiles), total sitting time (minutes/week), daily caloric consumption
(measured in kcal/day), and sleep duration. In addition, we included information on their participation
in prostate-specific antigen (PSA) testing prior to diagnosis (yes; no) to control for confounding by
screening history [26].
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2.5. Statistical Analyses
Participants’ follow-up time was calculated from their entry into the study (based on their exact
age when competing the study survey in 2008. For more details, visit the Alberta ’s Tomorrow Project
website: https://myatp.ca/resources/previous-surveys) to the date of cancer diagnosis (based on their
exact age when their incident prostate cancer was diagnosed) or to the date of linkage with the Alberta
Cancer Registry (based on their exact age at the time of data linkage). Subsequently, each participant
in the study contributed person-time equivalent to the time between completion of Survey 2008 to
their diagnosis, or to the time of linkage if diagnosis did not occur.
Descriptive analyses were conducted to assess participants’ characteristics according to the social
jetlag group (0–<1, 1–<2, and 2+ h) using t-tests and chi-square tests as appropriate. Means (standard
deviations) were calculated for continuous variables, and frequency percentages were calculated for
categorical variables. A directed acyclic graph (DAG) was used to identify potential confounders
a priori (Figure S1) including the following: age, marital status, the highest level of completed
education, total household income, employment status, smoking status, frequency of alcohol
consumption, recreational physical activity, total sitting time, pre-existence of medical conditions,
and chronotype. Cox proportional hazards regression models were used to estimate the age-adjusted
and multivariable-adjusted hazard ratios (HR) between categories of social jetlag (using the zero
social jetlag group as the reference group) and 95% confidence intervals (95% CI) for prostate cancer
incidence. Trends in social jetlag were assessed using the median value of each category of social jetlag
(i.e., 0.5 for 0–<1 h; 1.5 for 1–<3 h; 2.5 for 2+ h). In sensitivity analyses, the multivariable-adjusted
models were additionally adjusted for sleep duration and then adjusted for body mass index,
daily caloric consumption, family history of cancer, and PSA testing. All statistical analyses were
performed using Stata (v16.0). All statistical tests were 2-sided and statistical significance was set at
p < 0.05.
3. Results
Between baseline assessment and follow-up, there were a total of 250 incident prostate cancer
cases observed in the sample population of 7455 men enrolled in the ATP cohort. With a median
follow-up of 9.57 years, 68,499 person-years were available for analysis. Table 1 presents the baseline
sociodemographic characteristics, lifestyle factors, and screening behavior of this sample population,
stratified by social jetlag category (0–<1 h, 1–<2 h, and 2+ h).
Table 1. Descriptive statistics of the Alberta’s Tomorrow Project study population (n = 7455).
Participant Characteristics Social Jetlag Category
0–<1 h 1–<2 h 2+ h p-Values
Observations 3400 2204 1851
Total person-years of observation 31,125.98 20,332.94 17,040.15
Social jetlag (hours) 1 0.15 (0.24) 1.22 (0.27) 2.86 (1.37) <0.001
Follow-up time (years) 1 9.15 (1.62) 9.23 (1.48) 9.21 (1.46) 0.208
Age (years) 1 58.77 (9.26) 53.44 (8.14) 51.86 (7.21) <0.001
Sitting time (minutes/week) 1 19.30 (57.27) 20.81 (58.00) 23.04 (63.60) 0.092
Daily caloric consumption (kcal) 1 2164.79 (945.60) 2235.42 (964.35) 2273.67 (1001.16) <0.001
Sleep duration (hours) 1 7.82 (1.16) 7.96 (0.99) 8.04 (1.07) <0.001
Recreational PA (MET-hours/week) 1 0.011
Group 1 (0 h) 0.00 (0.00) 0.00 (0.00) 0.00 (0.00)
Group 2 (>0.00–4.00 h) 2.42 (1.01) 2.46 (1.01) 2.42 (1.03)
Group 3 (>4.00–8.25 h) 6.25 (1.37) 6.35 (1.29) 6.26 (1.27)
Group 4 (>8.25–16.00 h) 12.01 (2.03) 12.17 (2.06) 11.97 (2.14)
Group 5 (>16.00 h) 27.07 (11.03) 26.16 (8.91) 26.44 (9.14)
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Table 1. Cont.
Participant Characteristics Social Jetlag Category
0–<1 h 1–<2 h 2+ h p-Values
Body mass index (kg/m2) 2 0.540
Normal (18.5–<25) 737 (21.7) 515 (23.3) 396 (21.4)
Overweight (25–<30) 1662 (48.9) 1086 (49.3) 922 (49.8)
Obese (30+) 991 (29.1) 599 (27.2) 528 (28.5)
Missing 10 (0.3) 4 (0.2) 5 (0.3)
Marital status 2 0.002
Married, or living with someone 2846 (83.7) 1902 (86.3) 1524 (82.3)
Divorced, separated, or widowed 352 (10.4) 205 (9.3) 197 (10.7)
Single, never married 202 (5.9) 97 (4.4) 130 (7.0)
Education 2 <0.001
Some or all post-secondary 2456 (72.2) 1757 (79.7) 1475 (79.7)
High school or less 944 (27.8) 447 (20.3) 376 (20.3)
Employment status 2 <0.001
Currently employed 2008 (59.1) 1907 (86.5) 1754 (94.8)
Not currently employed 1392 (40.9) 297 (13.5) 97 (5.2)
Total household income 2 <0.001
$0–$49,999 842 (24.8) 266 (12.0) 191 (10.3)
$50,000–$99,999 1259 (37.0) 733 (33.3) 637 (34.4)
$100,000+ 1276 (37.5) 1198 (54.4) 1014 (54.8)
Missing 23 (0.7) 7 (0.3) 9 (0.5)
Smoking status 2 <0.001
Never 1390 (40.9) 1029 (46.7) 798 (43.1)
Former 1475 (43.4) 818 (37.1) 704 (38.0)
Current 533 (15.7) 357 (16.2) 349 (18.9)
Missing 2 (0.1) 0 (0.0) 0 (0.0)
Frequency of alcohol consumption 2 <0.001
Never 431 (12.7) 213 (9.7) 185 (10.0)
Rarely 606 (17.8) 381 (17.3) 332 (17.9)
Occasional 1160 (34.1) 856 (38.28) 707 (38.2)
Regular 316 (9.3) 176 (8.0) 127 (6.9)
Missing 887 (26.1) 578 (26.2) 500 (27.0)
Family history of cancer 2 0.539
Yes 2454 (72.2) 1632 (74.1) 1363 (73.6)
No 939 (27.6) 569 (25.8) 484 (26.2)
Missing 7 (0.2) 3 (0.1) 4 (0.2)
Pre-existence of medical conditions 2 <0.001
Yes 829 (24.4) 698 (31.7) 599 (32.4)
No 2571 (75.6) 1506 (68.3) 1252 (67.6)
PSA (prostate-specific antigen)
screening 2
Yes 1899 (55.9) 1053 (47.8) 801 (43.3)
No 1501 (44.1) 1151 (52.2) 1050 (56.7)
Chronotype 2 <0.001
Early 2085 (61.3) 790 (35.8) 327 (17.7)
Intermediate 797 (23.5) 795 (36.1) 547 (29.5)
Late 518 (15.2) 619 (28.1) 976 (52.7)
Missing 0 (0.0) 0 (0.0) 1 (0.1)
1 Denoted values: mean (standard deviation). 2 Denoted values: frequency (proportion of column total).
Table 2 shows the results for the age-adjusted and multivariable-adjusted HRs of prostate cancer
incidence for “usual” social jetlag, both overall and in each chronotype subgroup. Men who experienced
more than one-hour social jetlag (1–<2 h and 2+ h) had higher risks of prostate cancer than those
in the lowest social jetlag category (0–<1 h). These association were present in the age-adjusted
(1–<2 h: HR = 1.48, 95% CI: 1.09 to 2.00; 2+ hours: HR = 1.58; 95% CI: 1.12 to 2.22; p for trend = 0.004),
multivariable-adjusted (1–<2 h: HR = 1.52, 95% CI: 1.10 to 2.01; 2+ hours: HR = 1.69; 95% CI: 1.15 to
2.46; p for trend = 0.004, Figure 1), sleep duration adjusted (1–<2 h: HR = 1.49; 95% CI: 1.09 to 2.06;
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2+ hours: HR = 1.64, 95% CI: 1.12 to 2.41; p for trend = 0.006), and multivariable-adjusted models in
sensitivity analyses (1–<2 h: HR = 1.45; 95% CI: 1.05 to 2.01; 2+ h: HR = 1.54; 95% CI: 1.04 to 2.27;
p for trend = 0.018). When modeling with each of the chronotype subgroup, the increased prostate
cancer risk associated with greater social jetlag remained significant among early chronotypes in the
age-adjusted (1–<2 h: HR = 1.66; 95% CI: 1.08 to 2.54; 2+ hours: HR = 1.98, 95%C CI: 1.98, 95% CI: 1.11
to 3.52; p for trend = 0.04), multivariable-adjusted (1–<2 h: HR = 1.73, 95% CI: 1.12 to 2.68; 2+ hours:
HR = 2.10, 95% CI: 1.16 to 3.77; p for trend = 0.003), sleep duration-adjusted (1–<2 h: HR = 1.75, 95% CI:
1.12 to 2.72; 2+ hours: HR = 2.12, 95% CI: 1.18 to 3.83; p for trend = 0.003), and multivariable-adjusted
models in sensitivity analyses (1–<2 h: HR = 1.76; 95% CI: 1.13 to 2.75; 2+ hours: HR = 2.04, 95% CI:
1.11 to 3.74; p = 0.004) models.
Table 2. Hazard ratio estimates of prostate cancer incidence by social jetlag and chronotype in the
Alberta’s Tomorrow Project study.
Social
Jetlag
Age-Adjusted
Model
Multivariate-Adjusted
Model 1
Multivariate-Adjusted
Model 2
Multivariate-Adjusted
Model 3
Cases HR(95% CI) Cases
HR
(95% CI) Cases
HR
(95% CI) Cases
HR
(95% CI)
All chronotypes included
0–<1 h 117 1.00 (Reference value) 115 1.00 (Ref.) 115 1.00 (Ref.) 114 1.00 (Ref.)
1–<2 h 75 1.48 (1.09 to 2.00) 74 1.52 (1.10 to 2.01) 74 1.49 (1.09 to 2.06) 72 1.45 (1.05 to 2.01)
2+ h 58 1.58 (1.12 to 2.22) 58 1.69 (1.15 to 2.46) 58 1.64 (1.12 to 2.41) 55 1.54 (1.04 to 2.27)
p for
trend - 0.004 - 0.004 - 0.006 - 0.018
Early chronotypes only
0–<1 h 73 1.00 (Ref.) 72 1.00 (Ref.) 72 1.00 (Ref.) 71 1.00 (Ref.)
1–<2 h 33 1.66 (1.08 to 2.54) 33 1.73 (1.12 to 2.68) 33 1.75 (1.12 to 2.72) 33 1.76 (1.13 to 2.75)
2+ h 15 1.98 (1.11 to 3.52) 15 2.10 (1.16 to 3.77) 15 2.12 (1.18 to 3.83) 14 2.04 (1.11 to 3.74)
p for
trend - 0.004 - 0.003 - 0.003 - 0.004
Intermediate chronotypes only
0–<1 h 22 1.00 (Ref.) 22 1.00 (Ref.) 22 1.00 (Ref.) 22 1.00 (Ref.)
1–<2 h 23 1.51 (0.81 to 2.80) 23 1.43 (0.74 to 2.73) 23 1.35 (0.71 to 2.58) 21 1.20 (0.62 to 2.33)
2+ h 17 1.87 (0.94 to 3.75) 17 1.72 (0.82 to 3.62) 17 1.53 (0.72 to 3.22) 15 1.29 (0.59 to 2.80)
p for
trend - 0.071 - 0.150 - 0.263 - 0.518
Late chronotypes only
0–<1 h 22 1.00 (Ref.) 21 1.00 (Ref.) 21 1.00 (Ref.) 21 1.00 (Ref.)
1–<2 h 19 1.24 (0.65 to 2.34) 18 1.30 (0.65 to 2.61) 18 1.28 (0.64 to 2.57) 18 1.32 (0.65 to 2.68)
2+ h 26 1.28 (0.69 to 2.39) 26 1.39 (0.69 to 2.80) 26 1.35 (0.70 to 2.74) 26 1.38 (0.68 to 2.81)
p for
trend - 0.441 - 0.381 - 0.416 - 0.392
1 Adjusted for age, marital status, highest level of completed education, total household income, employment status,
smoking status, frequency of alcohol consumption, recreational physical activity, total sitting time, pre-existence of
medical conditions, and chronotype (all chronotype sub-table only). 2 Further adjusted for sleep duration. 3 Further
adjusted for body mass index, daily caloric consumption, family history of cancer, and PSA screening.
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Figure 1. Prostate cancer incidence by social jetlag categories in the Alberta’s Tomorrow Project
study (Adjusted for age, total household income, employment status, marital status, smoking status,
frequency of alcohol consumption, the highest level of completed education, recreational physical
activity, sitting time per week, pre-existence of medical conditions, and chronotype).
4. Discussion
To our knowledge, this investigation is among the first to demonstrate that social jetlag is associated
with an increased risk of prostate cancer. Drawing data from a large prospective cohort in Alberta,
Canada, both multivariable- and latency multivariable-adjusted models suggest that habitual social
jetlag greater than one hour may lead to a greater likelihood of developing prostate cancer compared
to no social jetlag. In addition, these associations may be modified by chronotype. Men with early,
but not intermediate or late, chronotypes may be exposed to an elevated risk of prostate cancer.
Increased prostate cancer risk has been associated with several markers of circadian disruption,
such as night shift work [8], living in longitude positions of delayed solar time (i.e., further west) in a
time zone [27], exposure to light at night [28], and sleep loss [29]. These negative health consequences
are often attributed to the discrepancy between an individual’s biological circadian clock and social
activities. Even though social jetlag is a prevalent form of circadian disruption, affecting 87% of the
working population [13], its role in the etiology of prostate cancer is vastly understudied.
Shift work has been the center of research attempting to unravel the link between circadian
disruption and cancer incidence and, in many ways, social jetlag resembles a mild form of shift
work. Most studies repeatedly suggest that night shift work favors oncogenesis [30] and particularly
increases the risk of breast, colorectal, and prostate cancer [7,8,31]. Night shift work presents a radical
disturbance to internal biological rhythm and is often accompanied by sleep deprivation, as a person
often finds it difficult to sleep when the internal circadian clock operates in waking mode regardless
of being tired after night shift work. This disturbance is proposed to be the cause of some health
consequences including elevated prostate cancer risk associated with rotating shift work [32].
In contrast, social jetlag is not necessarily a sleep-depriving behavior. Shifting sleep patterns
during weekends or free days to cope with sleep debt accumulated during weekdays may be
perceived as a justifiable behavioral choice for maintaining health and increasing cumulative sleep
time. Among individuals younger than 65 years old, evidence suggests that long weekend sleep
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may compensate for the increased mortality risk associated with short weekend sleep [33]. However,
recovery sleep during weekends does not appear to be an effective strategy to prevent metabolic
dysregulation associated with recurrent insufficient sleep [34]. Our results provide further evidence
that even the mild circadian misalignment associated with social jetlag may still be carcinogenic after
taking account of sleep duration.
The biological mechanisms relating to circadian disruption and cancer development are complex
and have been the focus of large-scale epidemiologic studies and controlled experimental studies,
mostly in animal models [9,35]. The majority of accumulating evidence has focused on the effects of night
shift work, which induces radical variations in exposure to light-dark and feeding cycles. This leads to
misalignments between the circadian system and environmental cues as well as desynchronization
among internal timing systems. Such discrepancies generate a profound influence on the temporal
alignment of genetic and metabolic processes [36]. The carcinogenic effect of shift work has also
been studied at the molecular level. For example, expression of the Period2 gene (Per2), a molecular
component of circadian clocks, has been found to have tumor-suppressive effects [37]. Per2 protein
levels were found to be downregulated in proliferative prostate cancer cells compared to normal
prostate cells, whereas melatonin treatment resulted in a resynchronization of oscillatory circadian
rhythm genes (Dbp and Per2) [38]. To date, no studies have provided evidence of metabolic or
molecular mechanisms that operate in the association between social jetlag and cancer development.
There are several biological pathways through which social jetlag may influence prostate carcinogenesis
(Figure S2). Social jetlag interacts with the sleep-wake cycle and contributes to circadian rhythm
disruption. Circadian rhythm disruption could directly increase the risk of metabolic dysfunction
such as obesity [15] and impaired circadian gene expression [39,40], both of which contribute to the
initiation of molecular dysregulations that promote prostate carcinogenesis [39,41–45]. Circadian
rhythm disruption may promote molecular dysregulation thus influence prostate cancer risk through
a direct pathway, such as increased cell proliferation, increased sex steroid hormone, and insulin
resistance [46]. While there may be similarities in the etiology, the influence of social jetlag may operate
differently than other forms of sleep disturbance, such as night shift work. Importantly, social jetlag
may not be associated with more exposure to light-at-night or sleep deprivation, both of which are
posited as explanations of the carcinogenic effect of circadian disruption [7,29,47].
In the current study, stratified analyses by the onset of sleep time yielded elevated prostate cancer
risk among subjects with early sleep preferences, based on a small number of incident cases. This is
intriguing, as evening chronotype has previously been associated with an increased risk of prostate
cancer in adults [48]. Our findings suggested that early chronotype may be more likely to be affected
by circadian disruptions, which was also the hypothesis in a study reporting an elevated risk of
type 2 diabetes with increased shift work duration among early chronotypes [49]. Future studies are
warranted to replicate the observed social jetlag-prostate cancer relationship. In addition, longitudinal
studies with a repeated measure on sleep patterns and highly controlled experimental studies are
necessary to not only confirm this relationship but to also elucidate the biologic mechanisms by which
social jetlag may increase the risk of prostate cancer. If the association between social jetlag and prostate
cancer risk is deemed casual, future prostate cancer screening programs may consider the inclusion of
social jetlag.
This study has several strengths. First, analyses were conducted in a large cohort study with
over 8 years of follow-up, offering adequate power for the analyses of the social jetlag-prostate cancer
relationship. No evidence to date has examined the social jetlag-prostate cancer risk based on a study
of such size and length. Second, the study measured a range of sociodemographic characteristics (age,
ethnicity, marital status, income, employment), behavioral factors (smoking [10,11,50,51] and alcohol
status [52], physical activity and sedentary behavior [53–56], daily caloric consumption [57,58]) and
physical conditions (body mass index [10,59], medical condition or comorbidity, and family history
of cancer) that are potentially relevant to prostate cancer risk. An additional adjustment for sleep
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duration in the model to account for the potential effect of differing lengths of sleep [6]. Results from
this model were similar to those from multivariate-adjusted models, offering compelling evidence.
Some limitations in this current study warrant discussion. First, although a number of covariates
are included in the multivariable-adjusted analyses, some important confounders were not examined,
such as the quality of sleep, the prevalence of sleep disorders, and the use of sleep medication.
Second, the sleep data were measured using a self-reported questionnaire, which may cause
misclassification of the exposure assessment, especially considering that poor recall is more likely to
occur among individuals with sleep disorders [60]. Third, the sleep data were measured once in this
study, which may not reflect the longitudinal changes in the population. Nevertheless, questions in
our survey specifically asked for the “usual” sleep time, providing information on the habitual
rather than a snapshot of sleep pattern. In addition, this measure may lead to a misclassification
of social jetlag, which would have attenuated an association between social jetlag and prostate
cancer risk and bias toward the null. However, a positive association was detected in the present
analysis. Future studies employing device-based measures to monitor the sleep-wake cycles over a
week or a monthly pattern that provide a robust measure of social jetlag to improve the exposure
assessment is encouraged. Forth, chronotype was estimated using tertiles of mid-sleep time on free
days, which may not reflect the true chronotype of the study participants but their chronotype tendency
in the analyzed sample. Fifth, the data were mostly collected from educated White men with relatively
high income who are more likely to get PSA testing, which may limit the generalizability of our results.
Finally, despite that Alberta province has the highest prostate cancer incidence rate in Canada [61],
the number of incident prostate cancer cases excluded the possibility of subgroup analyses by tumor
aggressiveness. This should be explored in future population-based studies with sufficient cases of
high-grade prostate cancer.
5. Conclusions
Our findings suggest that switching usual sleep patterns between weekday and weekend days
among men is associated with an increased prostate cancer risk, especially in those with an early
chronotype. Further population-based longitudinal studies are necessary to confirm these findings with
sufficient cases of high-grade prostate cancer, and well-controlled experimental studies are necessary
to elucidate the biological mechanism.
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